SARC-F and other screening tests for sarcopenia
| Autor: | Gulistan Bahat, Birkan Ilhan, Tugba Erdogan |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Sarcopenia
medicine.medical_specialty Nutrition and Dietetics Framingham Risk Score Future studies Frailty Screening test business.industry Adverse outcomes Medicine (miscellaneous) Anthropometry medicine.disease Test (assessment) Meta-Analysis as Topic Surveys and Questionnaires medicine Humans Mass Screening Intensive care medicine Risk assessment business Geriatric Assessment Aged |
| Zdroj: | Current Opinion in Clinical Nutrition & Metabolic Care. 25:37-42 |
| ISSN: | 1473-6519 1363-1950 |
| DOI: | 10.1097/mco.0000000000000801 |
| Popis: | PURPOSE OF REVIEW Sarcopenia screening tools can enable clinicians to select individuals for more demanding evaluations, and hence, may facilitate its timely diagnosis and management. The most common recommended screening test is SARC-F, whereas many others are proposed. We aimed to summarize the recent studies and evidence performed on SARC-F and other sarcopenia screening tools. RECENT FINDINGS Meta-analysis studies reported that despite having moderate-high specificity, SARC-F has low-moderate sensitivity to detect sarcopenia, which would cause a significant number of individuals having sarcopenia to be unrecognized. Several recent studies aimed to increase sensitivity and utility of SARC-F as a screening tool by i.e., application of lower cut-offs, adding extra-items, and combining with other screening tests. Some of these approaches increased its screening efficacy significantly. In line with its previous studies, SARC-F showed success to predict adverse outcomes in the latest studies as well. Recently, it has also been suggested as a reasonable screening test for frailty. In addition to the long-standing screening tests i.e., anthropometric measures, Ishii Test and Mini Sarcopenia Risk Assessment (MSRA) Questionnaire; new tests, i.e., Taiwan Risk Score for Sarcopenia, Sarcopenia Scoring Assessment Model (SarSA-Mod) and re-purposed tests, i.e., SARQoL questionnaire and fracture risk assessment tool have been investigated as potential screening tests for sarcopenia. Some of these tests performed as well as or superior to standard SARC-F. SUMMARY Screening of sarcopenia is critical for public health given its significant prevalence and adverse outcomes. SARC-F is the most recommended tool for screening but has low-moderate sensitivity. Studies performed recently indicate that its sensitivity can be increased by some attempts and it may be used as a reasonable test to screen frailty as well. Some other tests have also been developed/re-purposed for an efficient screening, needing to be tested for their performance and usability with future studies in different populations and settings. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|